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Abstract 
Counterfeit medicines represent a global public health problem which accounts for 
10% of the world market including 50% in some countries. Medicine counterfeiting 
can occur to any class of medicines, any type of formulation and can be encountered 
anywhere in the world. Consequently, rapid methods are needed to identify 
counterfeit medicines at their site of origin. Handheld spectroscopic techniques offer 
this advantage.  
This work features the use of near-infrared (NIR) and Raman spectroscopic methods 
for identification of counterfeit medicines obtained worldwide.  
A total of 300 branded and generic medicines were measured using five 
spectroscopic instruments; being two NIR and three Raman (of different laser 
wavelength). Spectra obtained from these instruments were exported into Matlab 
v2014b where multivariate classification and regression algorithms were applied. 
The results showed that the selection of the technique depended on the type of 
medicine used. Thus, NIR was more successful in authenticating branded medicines 
where the physicochemical properties were of interest. On the other hand, Raman 
was ideal for authenticating generic medicines where the chemical signature of the 
API and/or excipient(s) were the subject of analyses. Furthermore, where adequate 
number of batches were available, the application of multivariate algorithms offered 
more accurate classification of the medicines.  
In summary, both techniques alongside multivariate algorithms proposed rapid 
methods for identifying counterfeit branded and generic medicines worldwide.  
 
 
 
 
 
Introduction 
According to the World Health Organisation (WHO), counterfeit medicines are those 
which ‘are fraudulently and deliberately mislabelled according to identity or source’ 
[1]. Medicine counterfeiting represent a global health problem and account for 
around 10% of the world market; including 50% in some countries [2, 3]. The public 
health effects attributed to counterfeit medicines could range from treatment 
ineffectiveness to lethal effects. For example, counterfeit paracetamol containing 
diethylene glycol (a renal toxin) was attributed to the death of more than 500 children 
[4-6]. However, other long term effects can occur due to the use of counterfeit 
medicines such as drug resistance and epidemics [7].  
Medicine counterfeiting can occur to any pharmacological class, any formulation type 
and to both branded and generic medicines. Hence, it can occur to both life-style and 
life-saving (antibiotics, anticancer) products. Life-style products are those intended to 
improve the image and/or performance such as medicines used for blood pressure, 
erectile dysfunction and hypercholesterolemia. Moreover, life-saving products are 
those used for serious conditions such as infection, cancer and AIDS. All the 
aforementioned products could be branded or generic medicines. It is noteworthy to 
mention that the branded medicine is the innovator product and patent owner; 
whereas the generic medicine is the interchangeable product marketed after the 
expiry of the patent [8]. The defects in counterfeit medicines could be attributed to 
wrong packaging, coating, active pharmaceutical ingredient (API) and/or excipients 
[9]. According to the WHO, 60% of counterfeit medicines contain no API, 17% 
contain too much or too little API and 16% contain wrong constituents [10].  
Counterfeit medicines could be encountered anywhere across the wholesale supply 
chain in hospitals, industries, Internet, manufacturers, pharmacies, patient homes, 
retailers, street markets or with wholesalers. Furthermore, they can be found in any 
country or over the Internet. Thus, rapid, mobile and non-destructive methods are 
needed for identification of counterfeit medicines.  
Handheld near-infrared and Raman spectroscopic techniques offer this advantage 
[11, 12] as they can give the required information at the site of analysis and require 
no sample preparation. Subsequently, both handheld NIR and Raman were used for 
identifying counterfeit life-style and life-saving medicines [11-23]. In this respect, two 
options were encountered with the use of handheld spectroscopic instruments; being 
in-built identification algorithms or offline analysis. The inbuilt identification algorithms 
were quick and can give answers instantaneously yet less accurate option than 
offline analysis. Subsequently, the use of one or more multivariate algorithms offline 
offered more accurate identification [12]. 
Therefore, this study highlights the combination of NIR and Raman spectroscopic 
techniques with multiple spectral algorithms for the identification of counterfeit 
branded and generic medicines obtained from different countries worldwide. 
 
Methods 
A total of 300 branded and generic medicines obtained from 41 countries worldwide 
were used in this study. The corresponding APIs and excipients for these medicines 
were purchased from chemical suppliers. 
NIR spectra of these medicines were collected using both a palm-sized and 
handheld NIR spectrometers over the wavelength ranges of 1600-2400 nm and 950-
1650 nm respectively. Raman spectroscopy of medicines were collected using three 
handheld instruments with different laser wavelengths: 785 nm, 1064 nm and a dual 
laser. The wavenumber ranges used for the aforementioned three instruments were 
250-2000 cm-1, 250-2000cm-1 and 300-3200 cm-1. 
Using both NIR and Raman, tablets were measured as received from both sides. 
Capsule content, powders, creams and liquids were measured through transparent 
glass vials. For data analysis, NIR and Raman spectra were exported in Matlab 
v2014b where spectral pre-treatment and treatment were conducted. Spectral pre-
treatment made for NIR spectra using standard normal variate and first derivatives 
(SNV-D1). Spectral treatment was made using multivariate classification and 
quantification algorithms, being: correlation in wavelength/wavenumber space 
(CWS), distance method, principal component analysis (PCA) and partial least 
square regression (PLSR). 
 
Results and Discussion 
Medicines included in this study were of diverse pharmacological classes, types, 
constituents and formulations. Pharmacological classes included antibiotics, anti-
inflammatory as well as drugs working on cardiovascular, gastrointestinal, nervous 
and respiratory systems. Subsequently, the dose, constituents and therapeutic 
margin were different for each medicine. Furthermore, the types of medicines 
included both branded and generic medicines. The medicines were obtained from 
difference sources across the wholesale supply chain. Sources of medicines 
included hospitals, pharmacies, street markets, the Internet and wholesalers. All the 
aforementioned factors implicated the authentication approach in relation to the 
technique of choice and the identification/quantification algorithms. 
With the aforementioned scenario, an ideal technique would provide a rapid, portable 
and on-site approach for authenticating medicines [11, 22]. Handheld NIR and 
Raman spectroscopic techniques offered these advantages due to many factors 
including: Light weight (< 5 Kg), portability, operation under different environmental 
conditions (temperature, humidity), friendly interface, inbuilt algorithms and ability to 
export spectra for offline analysis [22]. Yet each spectroscopic technique had its 
advantages and disadvantages in relation to medicines’ authentication. This 
depended to a degree on the type of medicine (branded versus generic), chemical 
make-up (API, excipients and doses) and physical properties (colour, shape and 
particle size). Subsequently, both techniques were complementary in authenticating 
medicines. In this respect, NIR confirmed the medicines’ physicochemical properties; 
whereas, Raman inspected specific signatures for chemical constituents in 
medicines.  
 
Near-infrared spectroscopy 
NIR was ideal in authenticating branded medicines where the test product should 
match precisely the reference product with respect to its physicochemical properties. 
In this respect, the presence of the reference product was key in the authentication 
process. This was demonstrated by comparing the NIR spectra of the test and 
reference products. NIR was able to instantly detect specific differences in medicines 
due to physicochemical properties. These differences identified: Defects in coating, 
presence/absence of API/excipient(s), poor storage conditions (humidity), difference 
in grade of API/excipient(s) (particle size). Figure 1 shows the NIR spectra of 
authentic and counterfeit Plavix tablets with differences in coating, water content and 
API. The correlation coefficient (r) value between both spectra was 0.77 which 
identified the counterfeit batch.  
 
 
Figure 1 SNV-D1 treated NIR spectra of authentic (blue) and counterfeit (red) 
Plavix tablets measured using the palm-sized NIR spectrometer. 
 
Handheld NIR was also able to accurately classify manufacturing source of 
medicines despite being purchased from different countries. This was possible when 
adequate number of batches (> 20) of a medicine were available [23]. For instance, 
the combination of NIR and PCA was able to classify authentic and counterfeit 
Viagra medicines obtained from different sources worldwide (Figure 2). Thus, the 
authentic scores incorporated inside the 95% equal frequency ellipses which 
indicated the same manufacturing source. 
 
 
Figure 2 PCA scores plot of the SNV-D1 treated NIR spectra of authentic (red) 
and counterfeit (blue) Viagra tablets measured using the handheld NIR 
spectrometer with 95% equal frequency ellipses drawn around the authentic 
scores. 
 
Thus, NIR was ideal for identifying counterfeit branded medicines when the label 
claim was indicated and a reference medicine was available. However, this approach 
was not successful in authenticating generic medicines with difference 
physicochemical properties but similar APIs. 
 
Raman spectroscopy 
Raman offered an advantage in authenticating generic medicines where the 
signature of API and/or excipient(s) was of interest. Raman spectroscopy showed 
spectral features specific to Raman active constituents in a medicine product [13, 
24].  
Yet the Raman activity of the constituents was dependent on the laser wavelength 
used. Using the 785 nm wavelength, the Raman activity of the medicine was mainly 
dependent on the API [13]. Thus, APIs showed Raman active signatures provided 
they were present in high concentrations. Figure 3 shows the Raman spectra of 
paracetamol (generic) and Panadol (branded) which showed signature specific to 
their corresponding API (paracetamol).   
 
 
Figure 3 Raw Raman spectra of Panadol (blue) and test paracetamol (red) 
which proved authenticity (r = 0.99) measured using a handheld Raman 
spectrometer equipped with 785 nm laser wavelength. 
 
Subsequently, Raman spectroscopy (with 785 nm wavelength) was ideal for 
authenticating generic medicines with high concentration of API. However, in 
medicines with low concentration of APIs, the Raman spectra of the medicine were 
often masked by the fluorescence of the excipients [11]. In this respect, the choice of 
a longer laser wavelength (such as 1064 nm) or a dual laser would be an option. The 
use of 1064 nm laser wavelength removed fluorescence but resulted in less spectral 
resolution and lower sensitivity [13]. Nonetheless, the use of dual laser overcome all 
the issues in relation to fluorescence, spectral resolution and sensitivity. In this 
respect, the signature of the medicine showed spectral features corresponding to 
API and excipient(s). Figure 4 shows the Raman spectra of Viagra tablets which 
contained 16 % m/m of sildenafil citrate and showed spectral features for titanium 
dioxide, lactose (main excipient) and sildenafil citrate (Assi et al 2015). This was key 
in differentiating authentic and counterfeit Viagra tablets. Thus, the counterfeit tablets 
contained excess amount of sildenafil citrate, no lactose (main excipient) and had 
thinner film coating. Subsequently, the Raman spectra of authentic counterfeit Viagra 
against sildenafil citrate, lactose and titanium dioxide showed r values of 0.57, 0.47 
and 0.86 respectively. On the other hand, the counterfeit Viagra tablets showed r 
values of 0.83, 0.15 and 0.56 against sildenafil citrate, lactose and titanium dioxide 
respectively. Thus dual laser Raman was ideal in identifying chemical differences 
between authentic and counterfeit medicines when a reference product (from the 
same manufacturer of the test product) was available.  
 
 
Figure 4 Raw Raman spectra of (a) authentic Viagra tablet, (b) counterfeit 
Viagra tablet, (c) sildenafil citrate and (d) lactose measured using a handheld 
Raman instrument equipped with a dual laser wavelength [16]. 
 In the absence of a reference medicine, dual laser Raman was still able to identify 
counterfeit medicines if multiple authentic batches were available. In this respect, a 
clustering method (such as PCA or distance method) would be able to differentiate 
between authentic and counterfeit medicines. Figure 5 shows the clustering of 
authentic and counterfeit Cialis tablets. The counterfeit tablets showed higher 
distances than the authentic medicines; which indicated higher variability due to 
different manufacturers.  
 
 
Figure 5 Distance plot showing the clustering of the authentic (blue) and 
counterfeit (red) Cialis tablets measured using a handheld Raman instrument 
equipped with a dual laser wavelength. 
 
However, clustering was not effective in all cases especially with the diversity of 
genetic batches available on the market. Subsequently, a more quantitative 
approach was needed where the presence of API as well as its concentration were 
of interest. For instance, PLSR applied to Raman spectra of branded Ciproxin tablets 
was able to quantify the API in both branded and generic tablet obtained worldwide 
[25]. The accuracy of the prediction was variable between different batches and this 
was attributed partly to the diversity of the samples as well as the noise generated by 
the Raman instrument. 
 
Conclusion 
In summary, handheld spectroscopic techniques offered rapid, mobile and non-
destructive approach for identifying counterfeit medicines worldwide. Both NIR and 
Raman were complementary in authenticating branded and generic medicines. NIR 
gave an overview on the medicines’ physicochemical properties and hence was 
more suitable for authenticating branded medicines. On the other hand, Raman 
spectroscopy showed specific chemical signatures to constituents in the medicines 
and thus was more suitable for authenticating generic medicines. 
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